Newgenivf Group Limited Stock Performance
| NIVF Stock | 2.06 0.35 14.52% |
The company secures a Beta (Market Risk) of -4.09, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NewGenIvf Group are expected to decrease by larger amounts. On the other hand, during market turmoil, NewGenIvf Group is expected to outperform it. At this point, NewGenIvf Group has a negative expected return of -1.15%. Please make sure to verify NewGenIvf Group's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if NewGenIvf Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days NewGenIvf Group Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return (14.52) | Five Day Return (6.36) | Year To Date Return (75.30) | Ten Year Return (79.04) | All Time Return (79.04) |
1 | The Search Is Over NewGenIVF Inks Reverse Merger Agreement With European Wellness Investment Holdings | 12/13/2024 |
2 | NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline | 12/23/2024 |
3 | NewGen announces reverse stock split to meet Nasdaq rules - MSN | 01/31/2025 |
4 | Why Pinterest Shares Are Trading Higher By Over 20 Here Are 20 Stocks Moving Premarket - Benzinga | 02/07/2025 |
5 | NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated Febr... | 02/20/2025 |
6 | NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market | 02/28/2025 |
| Begin Period Cash Flow | 54.7 K |
NewGenIvf |
NewGenIvf Group Relative Risk vs. Return Landscape
If you would invest 698.00 in NewGenIvf Group Limited on December 2, 2024 and sell it today you would lose (492.00) from holding NewGenIvf Group Limited or give up 70.49% of portfolio value over 90 days. NewGenIvf Group Limited is currently does not generate positive expected returns and assumes 13.0635% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NewGenIvf, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NewGenIvf Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewGenIvf Group Limited, and traders can use it to determine the average amount a NewGenIvf Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0881
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NIVF |
Estimated Market Risk
| 13.06 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NewGenIvf Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewGenIvf Group by adding NewGenIvf Group to a well-diversified portfolio.
NewGenIvf Group Fundamentals Growth
NewGenIvf Stock prices reflect investors' perceptions of the future prospects and financial health of NewGenIvf Group, and NewGenIvf Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewGenIvf Stock performance.
| Current Valuation | 7.37 M | ||||
| Price To Book | 7.91 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 5.14 M | ||||
| EBITDA | 384.31 K | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 332.55 K | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Market Capitalization | 7.09 M | ||||
| Total Asset | 1.65 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
About NewGenIvf Group Performance
By analyzing NewGenIvf Group's fundamental ratios, stakeholders can gain valuable insights into NewGenIvf Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NewGenIvf Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewGenIvf Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 12.01 | 12.61 | |
| Return On Tangible Assets | (0.48) | (0.46) | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | (0.48) | (0.46) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about NewGenIvf Group performance evaluation
Checking the ongoing alerts about NewGenIvf Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewGenIvf Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewGenIvf Group generated a negative expected return over the last 90 days | |
| NewGenIvf Group has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 5.14 M. Net Loss for the year was (690.85 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewGenIvf Group generates negative cash flow from operations | |
| NewGenIvf Group has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market |
- Analyzing NewGenIvf Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewGenIvf Group's stock is overvalued or undervalued compared to its peers.
- Examining NewGenIvf Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewGenIvf Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewGenIvf Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewGenIvf Group's stock. These opinions can provide insight into NewGenIvf Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NewGenIvf Stock analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |